Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
892 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Condition: Uterine Cancer
Intervention: Drug: Celecoxib
22 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Cervical Cancer
Conditions: Cervical Intraepithelial Neoplasia;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Drug: Pemetrexed
23 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Conditions: Neoplasms;   Neoplasms by Site;   Urogenital Neoplasms;   Genital Neoplasms, Female;   Uterine Neoplasms;   Endometrial Neoplasms;   Cancer of Endometrium;   Endometrial Cancer;   Cancer of the Endometrium;   Endometrium Cancer;   Neoplasms, Endometrial
Intervention: Drug: pemetrexed
24 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy
25 Unknown  Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas
Interventions: Drug: Pazopanib plus Gemcitabine;   Drug: Pazopanib
26 Completed Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Drug: paclitaxel
27 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
28 Completed A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Procedure: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Drug: Carboplatin and Paclitaxel and Radiation Therapy
29 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
30 Completed Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy
Conditions: Breast Cancer;   Uterine Cancer;   Ovarian Cancer
Intervention: Behavioral: Music therapy
31 Completed Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Solid Neoplasm;   Lung Carcinoid Tumor;   Recurrent Digestive System Neuroendocrine Tumor G1;   Recurrent Renal Cell Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage III Renal Cell Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IV Renal Cell Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temsirolimus;   Biological: Trebananib
32 Active, not recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
33 Completed
Has Results
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
34 Terminated Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: paclitaxel
35 Terminated Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: gemcitabine hydrochloride
36 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
37 Recruiting A Mind-body Intervention to Improve Body and/or Self Image
Conditions: Breast Cancer;   Ovarian Cancer;   Uterine Cancer;   Cervical Cancer
Interventions: Behavioral: Hypnotic Relaxation Therapy;   Behavioral: Progressive Muscle Relaxation
38 Withdrawn A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Interventions: Biological: INO-3112 vaccine;   Radiation: Radiotherapy (Extrernal beam radiotherapy + brachytherapy);   Drug: Cisplatin chemotherapy
39 Completed
Has Results
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
40 Withdrawn BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Drug: BEZ235

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years